Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | 2022 | YoY |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | -34.75K | 73.64% |
| Net profit | -1.84M | 76.48% |
| EBITDA | -2.51M | 8.96% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €982.03 |
Number of shares | 10.83M |
52-week high/low | €0.00997 - €0.0000907 |
| Dividends | No |
Beta | 1.49 |
P/E ratio | 0.00 |
PEG ratio | 0.00 |
P/B ratio | 0.00 |
P/S ratio | 0.00 |
Company profile
Imagin Medical Inc. operates as a surgical imaging company focusing on bladder cancer. The company is developing the i/Blue Imaging System to meet the BLC needs of urologists. Imagin Medical Inc. was founded in 1986 and is headquartered in Vancouver, Canada.
| Name | Imagin Medical |
| CEO | E. James Hutchens |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| IPO | 01/23/2013 |
| Employees | 10 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | IMEXF |
Frankfurt | DPD3.F |
München | DPD3.MU |